Once you've spent your money and provide your data while applying for approval, then they may ask questions that you can't answer because no one asked the question before.
True. But now with the EMA, they are asking the "do or die" approval questions. So if what is being asked at the clockstop are softball questions.....that may influence willingness to spend on PR.
If EMA approves and AVXL gets the story of a safe, effective alz pill out to the American public, then some sort of accelerated approval becomes a possibility.